Literature DB >> 24193795

Perfusion characteristics of Moyamoya disease: an anatomically and clinically oriented analysis and comparison.

Gerrit Alexander Schubert1, Marcus Czabanka, Marcel Seiz, Peter Horn, Peter Vajkoczy, Claudius Thomé.   

Abstract

BACKGROUND AND
PURPOSE: Moyamoya disease (MMD) is characterized by unique angiographic features of collateralization. However, a detailed quantification as well as comparative analysis with cerebrovascular atherosclerotic disease (CAD) and healthy controls have not been performed to date.
METHODS: We reviewed 67 patients with MMD undergoing Xenon-enhanced computed tomography, as well as 108 patients with CAD and 5 controls. In addition to cortical, central, and infratentorial regions of interest, particular emphasis was put on regions that are typically involved in MMD (pericallosal territory, basal ganglia). Cerebral blood flow (CBF), cerebrovascular reserve capacity (CVRC), and hemodynamic stress distribution were calculated.
RESULTS: MMD is characterized by a significant, ubiquitous decrease in CVRC and a cortical but not pericallosal decrease in CBF when compared with controls. Baseline perfusion is maintained within the basal ganglia, and hemodynamic stress distribution confirmed a relative preservation of central regions of interest in MMD, indicative for its characteristic proximal collateralization pattern. In MMD and CAD, cortical and central CBF decreased significantly with age, whereas CVRC and hemodynamic stress distribution are relatively unaffected by age. No difference in CVRC of comparable regions of interest was seen between MMD and CAD, but stress distribution was significantly higher in MMD, illustrating the functionality of the characteristic rete mirabilis.
CONCLUSIONS: Our data provide quantitative support for a territory-specific perfusion pattern that is unique for MMD, including central preservation of CBF compared with controls and patients with CAD. This correlates well with its characteristic feature of proximal collateralization. CVRC and hemodynamic stress distribution seem to be more robust parameters than CBF alone for assessment of disease severity.

Entities:  

Keywords:  Moyamoya disease; Xenon; computed tomography; perfusion

Mesh:

Substances:

Year:  2013        PMID: 24193795     DOI: 10.1161/STROKEAHA.113.003370

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients.

Authors:  Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Allison O Scott; Carlos C Faraco; Melissa C Gindville; Lori C Jordan; Petrice M Cogswell; Angela L Jefferson; Howard S Kirshner; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2016-12-28       Impact factor: 6.200

2.  Using arterial spin labeling to measure cerebrovascular reactivity in Moyamoya disease: Insights from simultaneous PET/MRI.

Authors:  Moss Y Zhao; Audrey P Fan; David Yen-Ting Chen; Yosuke Ishii; Mohammad Mehdi Khalighi; Michael Moseley; Gary K Steinberg; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-02       Impact factor: 6.960

3.  Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.

Authors:  Kinga G Blecharz-Lang; Vincent Prinz; Małgorzata Burek; Dietmar Frey; Tobias Schenkel; Susanne M Krug; Michael Fromm; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-10       Impact factor: 6.200

4.  Recognition of Cognitive Impairment in Adult Moyamoya Disease: A Classifier Based on High-Order Resting-State Functional Connectivity Network.

Authors:  Yu Lei; Xi Chen; Jia-Bin Su; Xin Zhang; Heng Yang; Xin-Jie Gao; Wei Ni; Liang Chen; Jin-Hua Yu; Yu-Xiang Gu; Ying Mao
Journal:  Front Neural Circuits       Date:  2020-12-21       Impact factor: 3.492

5.  Time to peak and full width at half maximum in MR perfusion: valuable indicators for monitoring moyamoya patients after revascularization.

Authors:  Adam Huang; Chung-Wei Lee; Hon-Man Liu
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease-A Randomized Controlled Study.

Authors:  Jiali Xu; Qian Zhang; Gary B Rajah; Wenbo Zhao; Fang Wu; Yuchuan Ding; Bowei Zhang; Wenting Guo; Qi Yang; Xiurong Xing; Sijie Li; Xunming Ji
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

7.  Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease.

Authors:  Jia-Bin Su; Si-Da Xi; Shu-Yi Zhou; Xin Zhang; Shen-Hong Jiang; Bin Xu; Liang Chen; Yu Lei; Chao Gao; Yu-Xiang Gu
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.